Clindamycin Injection, Solution
Product Images NDC 25021-115

4 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 25021-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cli04 0021 01)

Structural Formula (Cli04 0021 01)
Chemical structure of clindamycin, depicting its molecular framework with labeled atoms and bonds clearly illustrating the compound's chemical composition.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cli04 0021 02)

Package Label – Principal Display Panel – Vial Label (Cli04 0021 02)
Clindamycin Injection, USP label from Sagent Pharmaceuticals for a 300 mg per 2 mL (150 mg per mL) single-dose vial intended for intramuscular or intravenous use. The label includes instructions to dilute before intravenous use and mentions that the solution is sterile and nonpyrogenic. Manufacturer information and storage instructions are also visible.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cli04 0021 03)

Package Label – Principal Display Panel – Vial Label (Cli04 0021 03)
Label for Clindamycin Injection, USP 600 mg per 4 mL (150 mg per mL) from Sagent Pharmaceuticals. The label indicates it is for intramuscular or intravenous use, single-dose vial. Instructions state to dilute before intravenous use. Storage instructions specify controlled room temperature (20 to 25°C) and refrigeration is not required. The label includes the NDC 25021-115 and barcode.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cli04 0021 04)

Package Label – Principal Display Panel – Vial Label (Cli04 0021 04)
Label for Clindamycin Injection, USP by Sagent Pharmaceuticals showing strength 900 mg per 6 mL (150 mg per mL) in a single-dose vial. Instructions for intramuscular or intravenous use and dilution before IV use are included. Storage information specifies temperature control and no refrigeration. Additional details about the drug's contents and preservatives are also displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.